US biotech Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
02:19
Sep 16
Sep 16
US biotech okay despite five percent yields
Even with 5% yields, US biotech is still not bad. The US biotech backdrop remains relatively resilient compared with domestic Korea biotech.
LOW
03:11
Jan 29
Jan 29
Consider US biotech and Japanese semis.
If investors feel they missed KOSPI and semiconductor gains, they can consider other assets that have delivered comparable or better returns: US biotech and Japanese semiconductors. US biotech also had the smallest recent six-month drawdown among the compared assets, though its five-year MDD has been around 45%.
MED
12:53
Jan 16
Jan 16
China biotech rises as US lags.
China's biotech industry has grown rapidly because China streamlined its drug development regulatory process, making it cheaper and faster to develop treatments and attracting capital away from US innovation hubs like Boston and San Francisco. Crowley says China now has over 4,000 true R&D biotech companies, up from a couple hundred a decade ago, and they are increasingly high-tech and doing things better and faster. He views this as one of the biggest threats to the US biotech industry, arguing the US needs a modernized, efficient FDA and a unique regulatory environment for rare diseases to outcompete China.
MED
22:50
Jan 07
Jan 07
US biotech broadly attractive
At the JPM Healthcare Conference, almost all US biotech companies are in an opportunity zone. The event creates discussions and potential deals, making US biotech broadly attractive.
MED
About US biotech Investor Commentary
Across the available history and selected sources, Buzzberg tracks US biotech across 2 sources: 3 bullish vs 0 bearish calls from 4 authors. Historical directional balance: 75% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 4 total trade ideas tracked. Past 7 days, before deduplication: 1 bullish. Latest voices: Park Ji-hoon, Lee Jong-han, John Crowley.